DOCS Stock Recent News

Doximity beat revenue and earnings estimates with its fiscal Q4 results. The company's guidance projects solid growth.

LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 9, 2022 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 17, 2024.

Doximity, Inc. (NYSE:DOCS ) Q4 2024 Earnings Conference Call May 16, 2024 5:00 PM ET Company Participants Perry Gold - Vice President Investor Relations Jeff Tangney - Co-Founder and Chief Executive Officer Anna Bryson - Chief Financial Officer Nate Gross - Co-Founder and Chief Strategy Officer Conference Call Participants Brian Peterson - Raymond James Scott Berg - Needham & Company Jared Hass - William Blair Richard Close - Canaccord Genuity Glen Santangelo - Jefferies Elizabeth Anderson - Evercore ISI Dan Clark - Leerink Partners Anne Samuel - JPMorgan Stan Berenshteyn - Wells Fargo Securities Stephanie Davis - Barclays Jack Wallace - Guggenheim Securities Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Scott Schoenhaus - KeyBanc Craig Hettenbach - Morgan Stanley Operator Thank you for standing by. My name is Greg and I will be your conference operator today.

Doximity (DOCS) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago.

LOS ANGELES , May 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 fourth quarter and fiscal year ended March 31, 2024. “We were pleased to beat on our top and bottom lines, as we delivered another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. “We're proud to bring AI and automation to clinical workflows, with over 580,000 unique providers usin.

NEW YORK , May 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the "Class Period"), of the important June 17, 2024 lead plaintiff deadline . SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

RADNOR, Pa. , May 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period").

Healthcare and beauty spending tend to be resilient in a wide range of economic environments. Doximity's platform capitalizes on essential needs in the healthcare industry, while generating most of its money from subscriptions for advertising, recruitment solutions, and other services.

Get a deeper insight into the potential performance of Doximity (DOCS) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.